No Level 4 CDC Travel Health Notice currently exists, as official CDC data confirm zero advisories at the “Avoid All Travel” threshold amid ongoing but contained outbreaks. The Democratic Republic of the Congo Ebola situation prompted a Level 3 notice in May 2026, with enhanced U.S. entry screening rather than a full travel ban, reflecting limited international spread and available precautions under CDC and WHO monitoring. Other active alerts, including meningococcal disease and chikungunya, remain at Level 2 or below. Historical patterns show Level 4 issuance only during extreme, uncontrolled health crises with no mitigation options; the current epidemiological picture and lack of rapid escalation support trader consensus favoring resolution to “No” by year-end. New model updates or case surges could alter this assessment before December.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado¿Los CDC emiten una advertencia de Nivel 4 antes del 31 de diciembre?
¿Los CDC emiten una advertencia de Nivel 4 antes del 31 de diciembre?
Sí
$71,755 Vol.
$71,755 Vol.
31 dic 2026
Sí
$71,755 Vol.
$71,755 Vol.
31 dic 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.No Level 4 CDC Travel Health Notice currently exists, as official CDC data confirm zero advisories at the “Avoid All Travel” threshold amid ongoing but contained outbreaks. The Democratic Republic of the Congo Ebola situation prompted a Level 3 notice in May 2026, with enhanced U.S. entry screening rather than a full travel ban, reflecting limited international spread and available precautions under CDC and WHO monitoring. Other active alerts, including meningococcal disease and chikungunya, remain at Level 2 or below. Historical patterns show Level 4 issuance only during extreme, uncontrolled health crises with no mitigation options; the current epidemiological picture and lack of rapid escalation support trader consensus favoring resolution to “No” by year-end. New model updates or case surges could alter this assessment before December.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Mercado abierto: Jan 19, 2026, 3:15 PM ET
Volumen
$71,755Fecha de finalización
31 dic 2026Mercado abierto
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.No Level 4 CDC Travel Health Notice currently exists, as official CDC data confirm zero advisories at the “Avoid All Travel” threshold amid ongoing but contained outbreaks. The Democratic Republic of the Congo Ebola situation prompted a Level 3 notice in May 2026, with enhanced U.S. entry screening rather than a full travel ban, reflecting limited international spread and available precautions under CDC and WHO monitoring. Other active alerts, including meningococcal disease and chikungunya, remain at Level 2 or below. Historical patterns show Level 4 issuance only during extreme, uncontrolled health crises with no mitigation options; the current epidemiological picture and lack of rapid escalation support trader consensus favoring resolution to “No” by year-end. New model updates or case surges could alter this assessment before December.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volumen
$71,755Fecha de finalización
31 dic 2026Mercado abierto
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...No Level 4 CDC Travel Health Notice currently exists, as official CDC data confirm zero advisories at the “Avoid All Travel” threshold amid ongoing but contained outbreaks. The Democratic Republic of the Congo Ebola situation prompted a Level 3 notice in May 2026, with enhanced U.S. entry screening rather than a full travel ban, reflecting limited international spread and available precautions under CDC and WHO monitoring. Other active alerts, including meningococcal disease and chikungunya, remain at Level 2 or below. Historical patterns show Level 4 issuance only during extreme, uncontrolled health crises with no mitigation options; the current epidemiological picture and lack of rapid escalation support trader consensus favoring resolution to “No” by year-end. New model updates or case surges could alter this assessment before December.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes